Improving protein pharmacokinetics by genetic fusion to simple amino acid sequences.
about
Trypanosoma cruzi trans-Sialidase in Complex with a Neutralizing Antibody: Structure/Function Studies towards the Rational Design of InhibitorsThe intrinsic disorder alphabet. III. Dual personality of serine.Continuous nonradioactive method for screening trypanosomal trans-sialidase activity and its inhibitors.Identification of glycoproteins targeted by Trypanosoma cruzi trans-sialidase, a virulence factor that disturbs lymphocyte glycosylationGenetic fusion of human FGF21 to a synthetic polypeptide improves pharmacokinetics and pharmacodynamics in a mouse model of obesity.Construction and analysis of variants of a polyvalent Lyme disease vaccine: approaches for improving the immune response to chimeric vaccinogens.The chemistry and biology of trypanosomal trans-sialidases: virulence factors in Chagas disease and sleeping sickness.The trans-sialidase, the major Trypanosoma cruzi virulence factor: Three decades of studies.Designing disorder: Tales of the unexpected tails.The Trypanosoma cruzi Surface, a Nanoscale Patchwork Quilt.Inactive trans-Sialidase Expression in iTS-null Trypanosoma cruzi Generates Virulent Trypomastigotes.Characterization of an aldolase-binding site in the Wiskott-Aldrich syndrome protein.The trans-sialidase from Trypanosoma cruzi triggers apoptosis by target cell sialylation.Evolution of a designed protein assembly encapsulating its own RNA genome.Immunological and pathological responses in BALB/c mice induced by genetic administration of Tc 13 Tul antigen of Trypanosoma cruzi.Half-Life Extension of Therapeutic Proteins via Genetic Fusion to Recombinant PEG MimeticsImmune system pathogenesis is prevented by the neutralization of the systemic trans-sialidase from Trypanosoma cruzi during severe infections
P2860
Q27676712-CFE39E47-F6C8-4D52-96F0-58DCB660D986Q30399038-1624C34B-2BA7-4BA6-A183-756214CE17FEQ33955766-2541F33D-4457-403A-9D50-F6BBE0FEE5E1Q33979079-18F510A7-32FA-472F-B02E-D13C4F57670BQ37034745-F0277A77-D961-4F60-BC7F-FBC7CE76B27EQ37228833-182931FC-5F54-420F-8498-8E97B1FBD256Q37940361-B29789CE-F741-43C1-BD81-E898CB5D99FAQ38557287-5900D4E9-16DC-4340-BDF2-C6EBC29AC63CQ38779715-D7F7515D-616F-4EE0-95B4-F7A5BA61C8AAQ39008597-F674726B-339C-4106-AE28-E624238871CDQ42372799-199285A3-AF54-472C-8FA9-D6EB70C9A8FEQ42673086-5121B002-6C6B-43A8-800A-CD76E19C4EE4Q44620292-658116C0-AB1C-4492-9555-31C8D57A4379Q47253184-BB049907-6346-4F02-8CF6-4EB7FAB16E49Q51984774-2B56D505-70F2-459E-BD06-167FE5C82C87Q57260227-36A30456-2DF3-4C8B-BEBE-875A1987AC96Q58855148-375E07BD-E603-43D5-8CCB-26D1E0281636
P2860
Improving protein pharmacokinetics by genetic fusion to simple amino acid sequences.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Improving protein pharmacokinetics by genetic fusion to simple amino acid sequences.
@en
Improving protein pharmacokinetics by genetic fusion to simple amino acid sequences.
@nl
type
label
Improving protein pharmacokinetics by genetic fusion to simple amino acid sequences.
@en
Improving protein pharmacokinetics by genetic fusion to simple amino acid sequences.
@nl
prefLabel
Improving protein pharmacokinetics by genetic fusion to simple amino acid sequences.
@en
Improving protein pharmacokinetics by genetic fusion to simple amino acid sequences.
@nl
P2860
P356
P1476
Improving protein pharmacokinetics by genetic fusion to simple amino acid sequences.
@en
P2093
Paula Alvarez
P2860
P304
P356
10.1074/JBC.M311356200
P407
P577
2003-11-11T00:00:00Z